Fetching results...
0 items found

A0481: Proclarix aids in resolving indeterminate multi-parametric magnetic resonance imaging for the improved diagnosis of prostate cancer

Mrs. M. (Miriam) Campistol Torres
Campistol Torres M.1, Morote J.1, Pye H.2, Athanasiou A.3, Celma A.1, Regis L.1, Planas J.1, Santamaria A.1, Trilla E.1, Schiess R.3, Punwani S.4, Whitaker H.2, Ahmed H.U.5, Emberton M.6
1Hospital Vall d'Hebron, Universitat Autònoma de Barcelona, Dept. of Urology, Barcelona, Spain, 2University College London, Molecular Diagnostics and Therapeutics Group, London, United Kingdom, 3Proteomedix AG, Dept. of Research & Development, Zurich-Schlieren, Switzerland, 4University College London, Centre for Medical Imaging, London, United Kingdom, 5Imperial College London, Dept. of Surgery and Cancer, London, United Kingdom, 6University College London, Division of Surgery and Interventional Science, London, United Kingdom
37th Annual EAU Congress
Date – Time - Location
03 July 2022, 10:30 - 12:00, Yellow Area, Room Forum
Abstract Session 26 - PCa localised imaging grade prediction, reporting and markers
Prostate Cancer, localised - Diagnosis, Markers
  • © 2023 European Association of Urology
  • Disclaimer